This Community is Archived.

While this community is no longer active, we invite you to review and recommend past posts and resources. Membership for this community is closed, but we hope you'll join us in one of the many other communities on GHDonline.

Moderators of Non-Communicable Diseases and GHDonline staff

You may use this brief for informational, non-commercial purposes with credit attribution: The Global Health Delivery Project, GHDonline.org, Aug 09, 2011. Please see our Terms of Use for more information.

Challenges and Opportunities in Funding Non-Communicable Diseases

Added on 09 Aug 2011
Last updated on 30 Aug 2013

Authors: By Robert Szypko; Reviewed By Rachel Nugent, PhD

Securing funding for expanded non-communicable disease (NCD) prevention and treatment in low- and middle-income countries is a major concern, particularly as the global burden of chronic conditions increases. Low- and middle-income countries confront nearly 80% of the global NCD disease burden, including cardiovascular disease, diabetes, cancer, and chronic respiratory disease (Alwan 2011). Many also rely on external funds to meet a share of their health needs, with donors providing nearly $1 in $6 spent on health care in the developing world. Especially in low-income countries, these largely preventable diseases will become increasingly expensive to manage the longer that the donor community waits to address them (Alwan 2011).

As the global health community prepared for a United Nations Summit on NCDs in September 2011, GHDonline hosted a discussion around the costs, funding sources, and priority shifting related to financing NCD prevention and treatment programs in resource-poor settings.  Researchers, doctors, business consultants, and other professionals discussed the challenges to expand funding for NCDs and examined ways that the public and private sectors can forge integrated solutions to address the pressing NCD challenges.

Key Points

  • Low-income developing countries rely on external funding to achieve health objectives, and although most global health donors recognize the magnitude of the NCD-related disease burden, funding for NCDs is lacking.
  • A global epidemiological transition is occurring, with mortality and morbidity due to NCDs rising as infectious disease-related death and illness decline.

Challenges in addressing NCDs

  • Addressing NCDs requires significantly more funding. For example, fully implementing cardiovascular disease prevention would require a 76 percent increase in global health expenditures.
  • NCD prevention efforts require long-term planning and don’t produce immediate benefits. As a result, acute crises in low-resource settings often take precedence.
  • Infectious disease projects often leave limited remaining funds for NCD efforts.
  • While donors may proclaim the need for NCD prevention efforts, they do not always follow through with funding.

Key Roles for NCD Donors and Advocates

  • Donors should work with leaders in the developing world to improve NCD-related service delivery systems, knowledge, and existing technology. Donor planning and project implementation must involve government ministries and other local actors to ensure project sustainability.
  • The indirect factors contributing to NCDs should be considered when designing program financing and implementation. For example, donors should support efforts to support education programs that advocate for healthier products, lifestyles, and work environments.
  • Donors should consider how to support local human resource development and expand local research capacity. Investing in higher education, such as public health schools, could support development of a cadre of local practitioners and researchers.
  • Changes to funding structures will require time, but advocates can work immediately on prioritizing policy change around tobacco, alcohol, and food.

Possibilities for Service Integration

  • NCD programs need not reinvent the wheel. Lessons from decades of scaling up infectious disease service can inform future efforts toward combating NCDs. A primary lesson is that early efforts must be designed so they are scalable and affordable.
  • Donors, advocates, and governments should prioritize operations research on low- and no-cost ways to integrate NCD programs into existing infrastructure and programs for infectious diseases, such as HIV, tuberculosis, and malaria, and also programs for promoting maternal and child health.
  • NCD efforts can be incorporated into some, but not all, primary care service systems.
  • National-level efforts should be aligned and coordinated across numerous ministries and sectors, such as the ministries of education, social welfare, transportation, and agriculture.

Role of the Private Sector

  • The private sector’s role in addressing NCDs cannot be ignored. Public health practitioners should be strategic in how they curtail harmful private-sector practices and conversely leverage the private sector’s expertise and funding to advance an agenda for a healthier future.
  • Advocates can encourage employers to keep their employees healthy through prevention and wellness programs, by emphasizing the economic advantages of lower employee absenteeism, lower health insurance premiums, and higher productivity.

Key References

Enrich the GHDonline Knowledge Base
Please consider replying to this discussion with the following information

  • If you currently work with NCDs or are involved in donor organizations, please post your experiences regarding funding NCD prevention and treatment programs.
  • If you are interested in NCD funding or are looking for advice in acquiring funding for an NCD project, consider posting your observations, questions and feedback.

Download: 08_09_11_Funding_Challenges_for_NCD.pdf (83.4 KB)